These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31607357)

  • 1. Exercise and substance abuse.
    Zhang L; Yuan TF
    Int Rev Neurobiol; 2019; 147():269-280. PubMed ID: 31607357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise, spinogenesis and cognitive functions.
    Zhang L; So KF
    Int Rev Neurobiol; 2019; 147():323-360. PubMed ID: 31607360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.
    Lynch WJ; Peterson AB; Sanchez V; Abel J; Smith MA
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1622-44. PubMed ID: 23806439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation.
    Sampedro-Piquero P; Ladrón de Guevara-Miranda D; Pavón FJ; Serrano A; Suárez J; Rodríguez de Fonseca F; Santín LJ; Castilla-Ortega E
    Neurosci Biobehav Rev; 2019 Nov; 106():23-48. PubMed ID: 30481530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise as an Adjunctive Treatment for Substance Use Disorders: Rationale and Intervention Description.
    Weinstock J; Farney MR; Elrod NM; Henderson CE; Weiss EP
    J Subst Abuse Treat; 2017 Jan; 72():40-47. PubMed ID: 27666958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.
    Nock NL; Minnes S; Alberts JL
    Birth Defects Res; 2017 Dec; 109(20):1711-1729. PubMed ID: 29251846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise in the context of substance use treatment: key issues and future directions.
    Abrantes AM; Blevins CE
    Curr Opin Psychol; 2019 Dec; 30():103-108. PubMed ID: 31079012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies.
    Hone-Blanchet A; Fecteau S
    Neuropharmacology; 2014 Oct; 85():81-90. PubMed ID: 24863044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of environmental enrichment for substance use disorders.
    Galaj E; Barrera ED; Ranaldi R
    Pharmacol Biochem Behav; 2020 Jan; 188():172829. PubMed ID: 31778722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders.
    Weinstock J; Barry D; Petry NM
    Addict Behav; 2008 Aug; 33(8):1072-5. PubMed ID: 18486352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of addiction.
    Clay SW; Allen J; Parran T
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theoretical reflection on the place of memory and temporal cognitive mechanisms in addictive disorders].
    Lalanne L; Laprevote V; Danion JM; Bacon E
    Encephale; 2016 Jun; 42(3):264-9. PubMed ID: 26875869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minding the brain: the role of pharmacotherapy in substance-use disorder treatment.
    Elias D; Kleber HD
    Dialogues Clin Neurosci; 2017 Sep; 19(3):289-297. PubMed ID: 29302226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic system activity under stress condition - seeking individual differences, preclinical studies.
    Gryz M; Lehner M; Wisłowska-Stanek A; Płaźnik A
    Psychiatr Pol; 2018 Jun; 52(3):459-470. PubMed ID: 30218562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug addiction: a curable mental disorder?
    Liu JF; Li JX
    Acta Pharmacol Sin; 2018 Dec; 39(12):1823-1829. PubMed ID: 30382181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
    Koob GF
    Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic and glutamatergic biomarkers disruption in addiction and regulation by exercise: a mini review.
    Abdullah M; Huang LC; Lin SH; Yang YK
    Biomarkers; 2022 Jun; 27(4):306-318. PubMed ID: 35236200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compulsivity in obsessive-compulsive disorder and addictions.
    Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
    Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.